Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2018

29.01.2018 | Pancreatic Tumors

Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis

verfasst von: Marc A. Attiyeh, MD, Jayasree Chakraborty, PhD, Alexandre Doussot, MD, PhD, Liana Langdon-Embry, BA, Shiana Mainarich, Mithat Gönen, PhD, Vinod P. Balachandran, MD, Michael I. D’Angelica, MD, Ronald P. DeMatteo, MD, William R. Jarnagin, MD, T. Peter Kingham, MD, Peter J. Allen, MD, Amber L. Simpson, PhD, Richard K. Do, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Pancreatic cancer is a highly lethal cancer with no established a priori markers of survival. Existing nomograms rely mainly on post-resection data and are of limited utility in directing surgical management. This study investigated the use of quantitative computed tomography (CT) features to preoperatively assess survival for pancreatic ductal adenocarcinoma (PDAC) patients.

Methods

A prospectively maintained database identified consecutive chemotherapy-naive patients with CT angiography and resected PDAC between 2009 and 2012. Variation in CT enhancement patterns was extracted from the tumor region using texture analysis, a quantitative image analysis tool previously described in the literature. Two continuous survival models were constructed, with 70% of the data (training set) using Cox regression, first based only on preoperative serum cancer antigen (CA) 19-9 levels and image features (model A), and then on CA19-9, image features, and the Brennan score (composite pathology score; model B). The remaining 30% of the data (test set) were reserved for independent validation.

Results

A total of 161 patients were included in the analysis. Training and test sets contained 113 and 48 patients, respectively. Quantitative image features combined with CA19-9 achieved a c-index of 0.69 [integrated Brier score (IBS) 0.224] on the test data, while combining CA19-9, imaging, and the Brennan score achieved a c-index of 0.74 (IBS 0.200) on the test data.

Conclusion

We present two continuous survival prediction models for resected PDAC patients. Quantitative analysis of CT texture features is associated with overall survival. Further work includes applying the model to an external dataset to increase the sample size for training and to determine its applicability.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP. Current standards of surgery for pancreatic cancer. Br J Surg. 2004;91(11):1410–1427.CrossRefPubMed Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP. Current standards of surgery for pancreatic cancer. Br J Surg. 2004;91(11):1410–1427.CrossRefPubMed
3.
Zurück zum Zitat Kneuertz PJ, Pitt HA, Bilimoria KY, et al. Risk of morbidity and mortality following hepato-pancreato-biliary surgery. J Gastrointest Surg. 2012;16(9):1727–1735.CrossRefPubMed Kneuertz PJ, Pitt HA, Bilimoria KY, et al. Risk of morbidity and mortality following hepato-pancreato-biliary surgery. J Gastrointest Surg. 2012;16(9):1727–1735.CrossRefPubMed
4.
Zurück zum Zitat Ferrone CR, Brennan MF, Gonen M, et al. Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg. 2008;12(4):701–706.CrossRefPubMed Ferrone CR, Brennan MF, Gonen M, et al. Pancreatic adenocarcinoma: the actual 5-year survivors. J Gastrointest Surg. 2008;12(4):701–706.CrossRefPubMed
5.
Zurück zum Zitat Birkmeyer JD, Siewers AE, Finlayson E V, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–1137.CrossRefPubMed Birkmeyer JD, Siewers AE, Finlayson E V, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002;346(15):1128–1137.CrossRefPubMed
6.
Zurück zum Zitat Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248–260.CrossRefPubMedPubMedCentral Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226(3):248–260.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293–298.CrossRefPubMedPubMedCentral Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240(2):293–298.CrossRefPubMedPubMedCentral
8.
9.
Zurück zum Zitat Ji F, Fu SJ, Guo ZY, et al. Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma. Med. 2016;95(27):e4065.CrossRefPubMedPubMedCentral Ji F, Fu SJ, Guo ZY, et al. Prognostic value of combined preoperative lactate dehydrogenase and alkaline phosphatase levels in patients with resectable pancreatic ductal adenocarcinoma. Med. 2016;95(27):e4065.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Distler M, Pilarsky E, Kersting S, Grutzmann R. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas: a retrospective tumor marker prognostic study. Int J Surg. 2013;11(10):1067–1072.CrossRefPubMed Distler M, Pilarsky E, Kersting S, Grutzmann R. Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas: a retrospective tumor marker prognostic study. Int J Surg. 2013;11(10):1067–1072.CrossRefPubMed
11.
Zurück zum Zitat Salmiheimo A, Mustonen H, Stenman UH, et al. Systemic inflammatory response and elevated tumour markers predict worse survival in resectable pancreatic ductal adenocarcinoma. PLoS ONE. 2016;11(9):e0163064.CrossRefPubMedPubMedCentral Salmiheimo A, Mustonen H, Stenman UH, et al. Systemic inflammatory response and elevated tumour markers predict worse survival in resectable pancreatic ductal adenocarcinoma. PLoS ONE. 2016;11(9):e0163064.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Poruk KE, Blackford AL, Weiss MJ, et al. Circulating tumor cells expressing markers of tumor initiating cells predict poor survival and cancer recurrence in patients with pancreatic ductal adenocarcinoma. Clin Cancer Res. 2017;23(11):2681–2690.CrossRefPubMed Poruk KE, Blackford AL, Weiss MJ, et al. Circulating tumor cells expressing markers of tumor initiating cells predict poor survival and cancer recurrence in patients with pancreatic ductal adenocarcinoma. Clin Cancer Res. 2017;23(11):2681–2690.CrossRefPubMed
13.
Zurück zum Zitat Haider S, Wang J, Nagano A, et al. A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Genome Med. 2014;6(12):105.CrossRefPubMedPubMedCentral Haider S, Wang J, Nagano A, et al. A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma. Genome Med. 2014;6(12):105.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Marchegiani G, Andrianello S, Malleo G, et al. Does size matter in pancreatic cancer?: Reappraisal of tumour dimension as a predictor of outcome beyond the TNM. Ann Surg. 2017;266(1):142–148.CrossRefPubMed Marchegiani G, Andrianello S, Malleo G, et al. Does size matter in pancreatic cancer?: Reappraisal of tumour dimension as a predictor of outcome beyond the TNM. Ann Surg. 2017;266(1):142–148.CrossRefPubMed
16.
Zurück zum Zitat Zhang H, Graham CM, Elci O, et al. Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy. Radiology. 2013;269(3):801-809.CrossRefPubMed Zhang H, Graham CM, Elci O, et al. Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy. Radiology. 2013;269(3):801-809.CrossRefPubMed
17.
Zurück zum Zitat Win T, Miles KA, Janes SM, et al. Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer. Clin Cancer Res. 2013;19(13):3591–3599.CrossRefPubMed Win T, Miles KA, Janes SM, et al. Tumor heterogeneity and permeability as measured on the CT component of PET/CT predict survival in patients with non-small cell lung cancer. Clin Cancer Res. 2013;19(13):3591–3599.CrossRefPubMed
18.
Zurück zum Zitat Simpson AL, Adams LB, Allen PJ, et al. Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. J Am Coll Surg. 2015;220(3):339–346.CrossRefPubMed Simpson AL, Adams LB, Allen PJ, et al. Texture analysis of preoperative CT images for prediction of postoperative hepatic insufficiency: a preliminary study. J Am Coll Surg. 2015;220(3):339–346.CrossRefPubMed
19.
Zurück zum Zitat Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.PubMedPubMedCentral Aerts HJ, Velazquez ER, Leijenaar RT, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.PubMedPubMedCentral
20.
Zurück zum Zitat Al-Hawary MM, Francis IR, Chari ST, et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology. 2014;270(1):248–260.CrossRefPubMed Al-Hawary MM, Francis IR, Chari ST, et al. Pancreatic ductal adenocarcinoma radiology reporting template: consensus statement of the Society of Abdominal Radiology and the American Pancreatic Association. Radiology. 2014;270(1):248–260.CrossRefPubMed
21.
Zurück zum Zitat Haralick Shanmugam K, Dinstein IR. Textural Features for Image Classification. IEEE Trans Syst Man Cybern. 1973;SMC-3(6):610–621. Haralick Shanmugam K, Dinstein IR. Textural Features for Image Classification. IEEE Trans Syst Man Cybern. 1973;SMC-3(6):610–621.
22.
Zurück zum Zitat Tang X. Texture information in run-length matrices. IEEE Trans Image Process. 1998;7(11):1602–1609.CrossRefPubMed Tang X. Texture information in run-length matrices. IEEE Trans Image Process. 1998;7(11):1602–1609.CrossRefPubMed
23.
Zurück zum Zitat Ojala T, Pietikäinen M, Harwood D. A comparative study of texture measures with classification based on feature distributions. Pattern Recognit. 1996;29(1):51–59.CrossRef Ojala T, Pietikäinen M, Harwood D. A comparative study of texture measures with classification based on feature distributions. Pattern Recognit. 1996;29(1):51–59.CrossRef
24.
Zurück zum Zitat Buczkowski S, Hildgen P, Cartilier L. Measurements of fractal dimension by box-counting: a critical analysis of data scatter. Physica A. 1998;252(1–2):23–34.CrossRef Buczkowski S, Hildgen P, Cartilier L. Measurements of fractal dimension by box-counting: a critical analysis of data scatter. Physica A. 1998;252(1–2):23–34.CrossRef
25.
Zurück zum Zitat Chakraborty J, Rangayyan RM, Banik S, Mukhopadhyay S, Leo Desautels JE. Statistical measures of orientation of texture for the detection of architectural distortion in prior mammograms of interval-cancer. J Electron Imaging. 2012;21(3):33010–33013.CrossRef Chakraborty J, Rangayyan RM, Banik S, Mukhopadhyay S, Leo Desautels JE. Statistical measures of orientation of texture for the detection of architectural distortion in prior mammograms of interval-cancer. J Electron Imaging. 2012;21(3):33010–33013.CrossRef
27.
Zurück zum Zitat Yoon SH, Lee JM, Cho JY, et al. Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology. 2011;259(2):442–452.CrossRefPubMed Yoon SH, Lee JM, Cho JY, et al. Small (≤ 20 mm) pancreatic adenocarcinomas: analysis of enhancement patterns and secondary signs with multiphasic multidetector CT. Radiology. 2011;259(2):442–452.CrossRefPubMed
28.
Zurück zum Zitat Kim JH, Park SH, Yu ES, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87–96.CrossRefPubMed Kim JH, Park SH, Yu ES, et al. Visually isoattenuating pancreatic adenocarcinoma at dynamic-enhanced CT: frequency, clinical and pathologic characteristics, and diagnosis at imaging examinations. Radiology. 2010;257(1):87–96.CrossRefPubMed
29.
Zurück zum Zitat Ichikawa T. A comparative study of histopathological findings and CT images related to pancreatic carcinomas. An attempt at diagnosis in tissue characterization by CT [in Japanese]. Nihon Ika Daigaku Zasshi. 1992;59(3):23–29. Ichikawa T. A comparative study of histopathological findings and CT images related to pancreatic carcinomas. An attempt at diagnosis in tissue characterization by CT [in Japanese]. Nihon Ika Daigaku Zasshi. 1992;59(3):23–29.
30.
Zurück zum Zitat Vyas SJ, Puri YS, John BJ, et al. Radiological tumor density and lymph node size correlate with survival in resectable adenocarcinoma of the pancreatic head: a retrospective cohort study. J Cancer Res Ther. 2016;12(1):417–421.CrossRefPubMed Vyas SJ, Puri YS, John BJ, et al. Radiological tumor density and lymph node size correlate with survival in resectable adenocarcinoma of the pancreatic head: a retrospective cohort study. J Cancer Res Ther. 2016;12(1):417–421.CrossRefPubMed
31.
Zurück zum Zitat Yue Y, Osipov A, Fraass B, et al. Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol. 2017;8(1):127–138.CrossRefPubMedPubMedCentral Yue Y, Osipov A, Fraass B, et al. Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol. 2017;8(1):127–138.CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Yamamoto T, Sugiura T, Mizuno T, et al. Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma. Ann Surg Oncol. 2015;22(2):677–684.CrossRefPubMed Yamamoto T, Sugiura T, Mizuno T, et al. Preoperative FDG-PET predicts early recurrence and a poor prognosis after resection of pancreatic adenocarcinoma. Ann Surg Oncol. 2015;22(2):677–684.CrossRefPubMed
33.
Zurück zum Zitat Hyun SH, Kim HS, Choi SH, et al. Intratumoral heterogeneity of 18F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma. Eur J Nucl Med Mol Imaging. 2016;43(8):1461–1468.CrossRefPubMed Hyun SH, Kim HS, Choi SH, et al. Intratumoral heterogeneity of 18F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma. Eur J Nucl Med Mol Imaging. 2016;43(8):1461–1468.CrossRefPubMed
34.
Zurück zum Zitat Okada T, Linguraru MG, Hori M, Summers RM, Tomiyama N, Sato Y. Abdominal multi-organ segmentation from CT images using conditional shape-location and unsupervised intensity priors. Med Image Anal. 2015;26(1):1–18.CrossRefPubMedPubMedCentral Okada T, Linguraru MG, Hori M, Summers RM, Tomiyama N, Sato Y. Abdominal multi-organ segmentation from CT images using conditional shape-location and unsupervised intensity priors. Med Image Anal. 2015;26(1):1–18.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Cai J, Lu L, Zhang Z, Xing F, Yang L, Yin Q. Pancreas Segmentation in MRI using Graph-Based Decision Fusion on Convolutional Neural Networks. Med Image Comput Comput Assist Interv. 2016;9901:442-450.PubMedPubMedCentral Cai J, Lu L, Zhang Z, Xing F, Yang L, Yin Q. Pancreas Segmentation in MRI using Graph-Based Decision Fusion on Convolutional Neural Networks. Med Image Comput Comput Assist Interv. 2016;9901:442-450.PubMedPubMedCentral
Metadaten
Titel
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis
verfasst von
Marc A. Attiyeh, MD
Jayasree Chakraborty, PhD
Alexandre Doussot, MD, PhD
Liana Langdon-Embry, BA
Shiana Mainarich
Mithat Gönen, PhD
Vinod P. Balachandran, MD
Michael I. D’Angelica, MD
Ronald P. DeMatteo, MD
William R. Jarnagin, MD
T. Peter Kingham, MD
Peter J. Allen, MD
Amber L. Simpson, PhD
Richard K. Do, MD, PhD
Publikationsdatum
29.01.2018
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2018
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6323-3

Weitere Artikel der Ausgabe 4/2018

Annals of Surgical Oncology 4/2018 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.